The insurers argued that McKinsey worked with Purdue Pharma – the...
Category:
Health
Latest
Will JN.1 drive a severe Covid wave in India?
As per the policy on COVID-19 testing, directed by the management,...
JN.1 variant dominates US with 50% of Covid cases: CDC
"JN.1 continues to cause an increasing share of infections and is...
17 pc dip in average fresh COVID-19 cases since 2nd Corona wave peak in May, says Union Health Ministry
The Union Health Ministry further added that a total of 51 Delta plus variant cases reported in India. In regard to the Moderna COVID-19 vaccine, Dr VK Paul, Member-Health of Niti Aayog said, “New drug permission has been granted to Moderna, the first internationally developed vaccine. This new drug permission is for restricted use.”
Cipla gets DCGI nod to import Moderna’s COVID-19 vaccine for restricted emergency use in India: Sources
According to the sources, approval is likely anytime as the Central Drugs Standard Control Organisation (CDSCO) is in favor of granting permission to Cipla for import of Moderna’s COVID-19 vaccine for restricted emergency use in India considering the pandemic situation in the country and the public interest.
Johnson & Johnson exploring ways to accelerate delivery of its COVID vaccine in India
‘We are in ongoing discussions with the Government of India and are exploring how best to accelerate our ability to deliver the Johnson & Johnson single dose COVID-19 vaccine to the people of India,” Johnson & Johnson India spokesperson said in a statement.
As per the recent announcement by the Drugs Controller General of India (DCGI), there is no longer a requirement to conduct bridging clinical studies of COVID-19 vaccines in India, the statement added.
Five Indian drugmakers to jointly start local trial of Merck & Co’s COVID-19 drug
Between March and April, each of these companies, including Sun Pharmaceutical Industries, Torrent Pharmaceuticals and privately held Emcure Pharmaceuticals, partnered with Merck to expand production of the drug, molnupiravir, hastening its availability in India to address a new wave of infections in the country.
Oxford study says mixing COVID-19 vaccines gives good protection
Professor Snape said these results are an invaluable guide to the use of mixed dose schedules, but the interval of four weeks studied here is shorter than the eight to 12-week schedule most commonly used for the Oxford-AstraZeneca vaccine.
Doubling time of coronavirus cases in India improves to 17.4 days: Health ministry
During the meeting with the cabinet secretary, the states were advised to focus on containment, testing and tracing, upgrading health infrastructure, clinical management and community engagement for effective management of COVID-19.
India’s vaccine shortage eases as inoculations outpace new registrations
Nearly half or 49% of the 60 and above population has been vaccinated with the first dose of Covid-19 vaccine. The percentage is 42% for those between 45 to 59 and 15% for those between 18-44 years. Total vaccine doses administered so far crossed the 33 crore mark on Tuesday.
Indian economy showing signs of pick-up up as the nation exits lockdowns
With the second Covid-19 wave now receding, the economy is already beginning to stir back to life.
A basket of high-frequency, alternative and market indicators such as retail activity and road congestion pointed to a pick up in the week to June 13, Abhishek Gupta, India economist at Bloomberg Economics, said in a report.
India records 46,148 new COVID-19 cases, 979 deaths
Around 32.36 crore vaccine doses have been administered so far under the country’s vaccination drive. India has achieved another milestone in COVID-19 vaccination and overtaken the USA in the total number of Covid Vaccine doses administered.
Don’t create panic about 3rd wave, basic manta is ‘precaution, no panic’: Jitendra Singh to docs
All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria said, ”As we now prepare for the possibility of the third wave and (the spread of) new variants like Delta Plus… we need to look ahead and see how we can strengthen our public health system focusing on lessons we have learnt from the past.”